Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
February 10, 2022
Tickers
ALNY
NVS
REGN
Tags
Trading Ideas
Biotech
Benzinga
From
Benzinga
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
Tickers
REGN
SNY
Tags
Health Care
Market News
Benzinga
From
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Tickers
AGLE
ALNY
ALVR
ARMP
Tags
ALVR
Offerings
LH
From
Benzinga
10 Biggest Price Target Changes For Tuesday
February 08, 2022
Tickers
CRNC
DDOG
MCK
REGN
Tags
DDOG
CRNC
Price Target
From
Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
PFE
LLY
MRK
From
MarketWatch
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
Cathie Wood
MRK
Long Ideas
From
Benzinga
Could This New Indication Create a Blockbuster for Pfizer?
February 05, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
PFE
Market News
ABBV
From
Motley Fool
This Will Put a Big Dent in Eli Lilly's and Regeneron's Sales This Year
February 04, 2022
Tickers
LLY
PFE
REGN
Tags
Recent Press Releases
REGN
PFE
From
Motley Fool
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
GSK
MRK
REGN
From
MarketWatch
Regeneron's Q4 Sales, Profits More Than Double With Boost From COVID-19 Treatment Sales
February 04, 2022
Tickers
REGN
Tags
Benzinga
Market News
Health Care
From
Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
Tickers
AKRO
BMY
GLPG
IBB
Tags
GLPG
Earnings
IBB
From
Benzinga
Recap: Regeneron Pharmaceuticals Q4 Earnings
February 04, 2022
Tickers
REGN
Tags
Earnings
REGN
Benzinga
From
Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
Tickers
ADNT
AON
APD
BBU
Tags
TWST
Earnings Scheduled
Markets
From
Benzinga
Earnings Preview For Regeneron Pharmaceuticals
February 03, 2022
Tickers
REGN
Tags
Market News
Benzinga
Earnings
From
Benzinga
What This FDA News Could Mean for Pfizer
February 01, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
GILD
Market News
LLY
From
Motley Fool
Should Investors Sell Eli Lilly After This Recent Regulatory News?
February 01, 2022
Tickers
LLY
REGN
Tags
LLY
Market News
Recent Press Releases
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
Tickers
AGIO
AMYT
ATXI
CTIC
Tags
FDA
REGN
Small Cap
From
Benzinga
3 Biotech Stocks That Could Boom or Bust in Q1
February 01, 2022
Tickers
OCGN
REGN
VRTX
Tags
Hot Stocks
Market News
NASDAQ:VRTX,NASDAQ:REGN,NASDAQ:OCGN
From
InvestorPlace
5 Things To Expect This Week
January 31, 2022
Tickers
AAPL
AMD
AMZN
APPS
Tags
SNY
GOOGL
AMZN
From
InvestorPlace
Analyst Ratings For Regeneron Pharmaceuticals
January 31, 2022
Tickers
REGN
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
GILD
JNJ
MRK
From
Benzinga
CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation
January 31, 2022
Tickers
REGN
SNY
Tags
Briefs
asthma
REGN
From
Benzinga
Market corrections are good buying opportunities, says Goldman Sachs — but only when this happens
January 31, 2022
Tickers
CTRA
LPX
MRNA
REGN
Tags
MRNA
LPX
SWKS
From
MarketWatch
A Deep Dive Into the Video Game Industry
January 29, 2022
Tickers
AAL
AAPL
AMZN
ATVI
Tags
RH
AMZN
RBLX
From
Motley Fool
Can AbbVie Beat Pfizer in the Atopic Dermatitis Market?
January 29, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
SNY
Recent Press Releases
REGN
From
Motley Fool
Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use
January 28, 2022
Tickers
REGN
SNY
Tags
Briefs
REGN
FDA
From
Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Tickers
ALXO
BGNE
BIIB
IBB
Tags
Earnings
Penny Stocks
SNY
From
Benzinga
J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
January 27, 2022
Tickers
BNTX
DRG
IBB
JNJ
Tags
SPX
REGN
BNTX
From
MarketWatch
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
Tickers
BNTX
GSK
LLY
MRK
Tags
MRK
GSK
PFE
From
MarketWatch
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
January 25, 2022
Tickers
AXP
BRO
IBM
JNJ
Tags
AXP
TSLA
Global
From
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.